![]() |
|
|
Molecular Pharmacology, Vol 20, 35-42, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics
1 Laboratory of Organ Function and Toxicology, National Institute of Environmental Health Sciences, Research Triangle
Park, North Carolina 27709
This study investigates binding characteristics of three derivatives of the estrogenic
mycotoxin zearalenone by components of liver cytosol. Studies show that cytosol from
male and female rats contain similar amounts of specific estrogen receptors which
sediment in the 8-9 S region of 5-20% sucrose gradients. In addition, male liver cytosol
contains a second class of "nonreceptor" estrogen-binding sites sedimenting in the 4-5 S
region of sucrose gradients. Sedimentation analyses show that each of the mycotoxin
derivatives (P-1496, P-1502, and P-1560) behave in an analogous manner to the synthetic
estrogen, diethylstilbestrol, in that they compete effectively for 8 S receptor sites, whereas
they bind poorly to 4 S nonreceptor sites. The binding affinities of the derivatives for
receptor sites were determined from competition studies at 4° by using partially purified
receptors and a range of concentrations of the competing ligands. During a short (90-min)
incubation period, the relative binding affinities of P-1496, P-1502, and P-1560 for receptor
sites were 30, 17, and 12%, respectively, of that exhibited by 17
-estradiol. The relative
binding affinity of 17
-estradiol and P-1496 did not change as a function of time at 4°.
However, the relative binding affinities of P-1502 and P-1560 decreased to 6.8 and 4.2%,
respectively, during an extended incubation period at 4°. The binding affinity of each
derivative was similar towards partially purified liver and uterine receptors during the
extended incubation period. Dissociation rate constants of 17
-estradiol, P-1496, and P-1560 were obtained indirectly by measuring the rate of exchange of the unlabeled ligand
with [3H]estradiol at 25°. The dissociation rate constants were 3.0 x 10-3 min-1, 5.6 x
10-3 min-1, and 0.14 min-1 for 17
-estradiol, P-1496, and P-1560, respectively. These
studies show that the mycotoxin derivatives have the potential for modulating liver
function through interaction with specific estrogen receptors. The true estrogen potential
of the derivatives may depend upon the formation of a stable slowly dissociating ligand-receptor complex.
This article has been cited by other articles:
![]() |
J. A. McLachlan Environmental Signaling: What Embryos and Evolution Teach Us About Endocrine Disrupting Chemicals Endocr. Rev., June 1, 2001; 22(3): 319 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Feldman, P. Stathis, M. Hirst, E. Stover, and Y. Do Saccharomyces cerevisiae produces a yeast substance that exhibits estrogenic activity in mammalian systems Science, June 8, 1984; 224(4653): 1109 - 1111. [Abstract] [PDF] |
||||
![]() |
D Feldman, Y Do, A Burshell, P Stathis, and D. Loose An estrogen-binding protein and endogenous ligand in Saccharomyces cerevisiae: possible hormone receptor system Science, October 15, 1982; 218(4569): 297 - 298. [Abstract] [PDF] |
||||